Kanda Sorn-In

Dr. Kanda Sorn-In


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
PNPathamakorn Netayawijit
Pathamakorn Netayawijit
Wirapong ChansanamWirapong Chansanam
Wirapong Chansanam
KSKanda Sorn-In
Kanda Sorn-In
Background: Class imbalance and limited interpretability remain major barriers to the clinical adoption of machine learning in diabetes prediction. These challenges often result in poor sensitivity to high-risk cases and reduced trust in AI-based decision support. This study addresses these limitations by integrating SMOTE-based resampling with SHAP-driven explainability, aiming to enhance both predictive performance and clinical transparency for real-world deployment. Objective: To develop and validate an interpretable machine learning framework that addresses class imbalance through advanced resampling techniques while providing clinically meaningful explanations for enhanced decision support. This study serves as a methodologically rigorous proof-of-concept, prioritizing analytical integrity over scale. While based on a computationally feasible subset of 1500 records, future work will extend to the full 100,000-patient dataset to evaluate scalability and external validity. We used the publicly available, de-identified Diabetes Prediction Dataset hosted on Kaggle, which is synthetic/derivative and not a clinically curated cohort. Accordingly, this study is framed as a methodological proof-of-concept rather than a clinically generalizable evaluation. Methods: We implemented a robust seven-stage pipeline integrating the Synthetic Minority Oversampling Technique (SMOTE) with SHapley Additive exPlanations (SHAP) to enhance model interpretability and address class imbalance. Five machine learning algorithms—Random Forest, Gradient Boosting, Support Vector Machine (SVM), Logistic Regression, and XGBoost—were comparatively evaluated on a stratified random sample of 1500 patient records drawn from the publicly available Diabetes Prediction Dataset (n = 100,000) hosted on Kaggle. To ensure methodological rigor and prevent data leakage, all preprocessing steps—including SMOTE application—were performed within the training folds of a 5-fold stratified cross-validation framework, preserving the original class distribution in each fold. Model performance was assessed using accuracy, area under the receiver operating characteristic curve (AUC), sensitivity, specificity, F1-score, and precision. Statistical significance was determined using McNemar’s test, with p-values adjusted via the Bonferroni correction to control for multiple comparisons. Results: The Random Forest-SMOTE model achieved superior performance with 96.91% accuracy (95% CI: 95.4–98.2%), AUC of 0.998, sensitivity of 99.5%, and specificity of 97.3%, significantly outperforming recent benchmarks (p < 0.001). SHAP analysis identified glucose (SHAP value: 2.34) and BMI (SHAP value: 1.87) as primary predictors, demonstrating strong clinical concordance. Feature interaction analysis revealed synergistic effects between glucose and BMI, providing actionable insights for personalized intervention strategies. Conclusions: Despite promising results, further validation of the proposed framework is required prior to any clinical deployment. At this stage, the study should be regarded as a methodological proof-of-concept rather than a clinically generalizable evaluation. Our framework successfully bridges algorithmic performance and clinical applicability. It achieved high cross-validated performance on a publicly available Kaggle dataset, with Random Forest reaching 96.9% accuracy and 0.998 AUC. These results are dataset-specific and should not be interpreted as clinical performance. External, prospective validation in real-world cohorts is required prior to any consideration of clinical deployment, particularly for personalized risk assessment in healthcare systems.

9 November 2022 in Energies
Verified
Journal Article
Open access
PDF file
MKMr. Thongsavanh KEOKHOUNGNING
Mr. Thongsavanh KEOKHOUNGNING
SPSuttichai Premrudeepeechacharn
Suttichai Premrudeepeechacharn
WWWullapa Wongsinlatam
Wullapa Wongsinlatam
Ariya NamvongAriya Namvong
Ariya Namvong
TRTawun Remsungnen
Tawun Remsungnen
CSChayada Surawanitkun
Chayada Surawanitkun
The complexity and uncertainty of power sources connected to transmission networks need to be considered. Planners need information on the sustainability and economics of transmission network expansion planning (TNEP). This work presents a newly proposed method for TNEP that considers high-penetration solar energy by using the particle swarm optimization (PSO) algorithm. The power sources, thermal and hydropower plants, and conditions of load were set in the account, including an uncertain power source and solar energy (PV). The optimal sizing and locating of the PV to be connected to the network were determined by the PSO. The PV grid code was set in the account. The new line’s investment cost and equipment was analyzed. The PV cost was considered based on the power loss, and the system’s reliability was improved. The IEEE 118 bus test system and Lao PDR’s system were requested to test the proposed practice. The results demonstrate that the proposed TNEP method is robust and feasible. The simulation results will be applied to guide the power system planning of Lao PDR.